Dasatinib
- TRADE NAME: Sprycel (Bristol-Myers Squibb)
- INDICATIONS: Leukemia (chronic myeloid); acute lymphoblastic leukemia
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Bcr-Abl tyrosine kinase inhibitor / (Breakpoint cluster region Abelson (Bcr-Abl) tyrosine kinase inhibitor, Tyrosine kinase inhibitor, Vascular endothelial growth factor (VEGF) inhibitor / antagonist
- HALF-LIFE: 3–5 hours
Abciximab, Alfentanil, Alfuzosin, Ambrisentan, Antacids, Anticoagulants, Antiplatelet agents, Aprepitant, Argatroban, Artemether/Lumefantrine, Astemizole, Atazanavir, Atorvastatin, Boceprevir, Cabazitaxel, Carbamazepine, Chloroquine, Ciclesonide, Cilostazol, Cinacalcet, Ciprofloxacin, Cisapride, Clarithromycin, Clopidogrel, Clozapine, Colchicine, Conivaptan, Cyclosporine, CYP3A4 inhibitors, inducers and substrates, Dabigatran, Darunavir, Deferasirox, Dexamethasone, Dihydroergotamine, Docetaxel, Dronedarone, Efavirenz, Eptifibatide, Ergotamine, Erythromycin, Eszopiclone, Famotidine, Fentanyl, Fesoterodine, Gadobutrol, Gefitinib, H2 antagonists, Indinavir, Itraconazole, Ixabepilone, Ketoconazole, Lopinavir, Lurasidone, Maraviroc, Meloxicam, Nefazodone, Nelfinavir, Nilotinib, Omeprazole, Pantoprazole, Phenobarbital, Phenytoin, Pimozide, Proton pump inhibitors, QT prolonging agents, Quinidine, Quinine, Rifampin, Ritonavir, Saquinavir, Saxagliptin, Sildenafil, Simvastatin, Sirolimus, St John's Wort, Tacrolimus, Tadalafil, Temsirolimus, Terfenadine, Tetrabenazine, Thioridazine, Tiagabine, Tinzaparin, Vardenafil, Ziprasidone
PREGNANCY CATEGORY: D
Please login to see the rest of this drug profile
Page last updated 02/25/2024
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric